Trials / Recruiting
RecruitingNCT06577792
Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)
Lobectomy-First Versus Lymphadenectomy-First Surgical Approach on Long-Term Survival in Operable Non-Small Cell Lung Cancer Patients: A Prospective, Multi-Center, Randomized Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 620 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
During the surgery for non-small cell lung cancer (NSCLC), lymphadenectomy or lobectomy are performed first, different surgeons have different choices. Oncology textbooks require dissecting distant lymph nodes (LNs) first and then dissecting nearby LNs. According to this requirement, thoracic surgeons should first perform lymphadenectomy and then lobectomy. Unfortunately, there is no high-level evidence to prove which surgical sequence is more beneficial to the long-term survival of NSCLC patients. In this multi-center randomized controlled trial (RCT), patients with stage I-II NSCLC were enrolled as the research object to determine which surgical sequence (lymphadenectomy-first vs. lobectomy-first) is better for the short-term and long-term outcomes in NSCLC patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Lobectomy-First | During the surgical treatment for patients with NSCLC, thoracic surgeons should perform lobectomy first, and then perform lymphadenectomy next. |
| PROCEDURE | Lymphadenectomy-First | During the surgical treatment for patients with NSCLC, thoracic surgeons should perform lymphadenectomy first, and then perform lobectomy next. |
Timeline
- Start date
- 2023-08-16
- Primary completion
- 2025-12-31
- Completion
- 2030-12-31
- First posted
- 2024-08-29
- Last updated
- 2025-05-16
Locations
26 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06577792. Inclusion in this directory is not an endorsement.